Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways. (Q38597826)
Jump to navigation
Jump to search
scientific article published on September 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways. |
scientific article published on September 2017 |
Statements
Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways (English)
Yanxia Guo
Xuefeng Yin
Helen Weedon
Susanna M Proudman
Malcolm D Smith
1 September 2017
1 reference
limma
1 reference
1 reference
1 reference
1 reference